Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00243919 · ClinicalTrials.gov registry record · Phase 3
Locomotor Experience Applied Post Stroke Trial
A Phase 3 study of Stroke, sponsored by Duke University.
- Completed
- Registry status
- Phase 3
- Development phase
- 408
- Enrollment target
- 8
- Study locations
NCT00243919 is a Phase 3 study of Stroke that has completed, run by Duke University. The registered enrollment target is 408 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (97% lower). The trial reports 8 study locations across 3 states.
The verdict
NCT00243919, a Phase 3 study of Stroke, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 408 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this study is to compare two different treatments to improve walking after stroke (or post-stroke).
Conditions Studied
Interventions
- BEHAVIORAL Home Exercise Program
- BEHAVIORAL Early locomotor training program
- BEHAVIORAL Late locomotor training program
Study Locations (8)
California
- Centinela Freeman Memorial Hospital - Inglewood
- Long Beach Memorial Hospital - Long Beach
- University of Southern California - PT Associates - Los Angeles
- Sharp Memorial Rehabilitation Center - San Diego
Florida
- University of Florida - Gainesville
- Brooks Rehabilitation Hospital - Jacksonville
- Florida Hospital - Orlando
North Carolina
- Duke University (Administrative Coordinating Center) - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 408 participants |
| Start Date | 2006-04 |
| Est. Completion | 2012-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00243919
The ClinicalTrials.gov registry entry for NCT00243919 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 408 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (97% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 3 interventions - of which Home Exercise Program is the first listed.
NCT00243919 reports 8 study locations spanning 3 distinct geographic areas - top geographies include California, Florida, North Carolina.
Frequently Asked Questions
What is clinical trial NCT00243919 about?
NCT00243919 is a clinical study titled "Locomotor Experience Applied Post Stroke Trial". The purpose of this study is to compare two different treatments to improve walking after stroke (or post-stroke).
What is the current status of trial NCT00243919?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 408 participants. The study started on 2006-04. Estimated completion is 2012-06.
What conditions does trial NCT00243919 study?
This clinical trial studies the following conditions: Stroke.
What interventions are being tested in trial NCT00243919?
The interventions under investigation include: Home Exercise Program (BEHAVIORAL), Early locomotor training program (BEHAVIORAL), Late locomotor training program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00243919?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00243919 being conducted?
This trial has 8 study locations across California, Florida, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
RECRUITING · Phase 3
-
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
ACTIVE NOT RECRUITING · Phase 3
-
Vitamin Therapy for Prevention of Stroke
COMPLETED · Phase 3
-
Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
COMPLETED · Phase 3
-
Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
COMPLETED · Phase 3
-
Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.